Epidemiology of esophageal cancer.

Esophageal cancer (EsC) is one of the least studied and deadliest cancers worldwide because of its extremely aggressive nature and poor survival rate. It ranks sixth among all cancers in mortality. In retrospective studies of EsC, smoking, hot tea drinking, red meat consumption, poor oral health, low intake of fresh fruit and vegetables, and low socioeconomic status have been associated with a higher risk of esophageal squamous cell carcinoma. Barrett's esophagus is clearly recognized as a risk factor for EsC, and dysplasia remains the only factor useful for identifying patients at increased risk, for the development of esophageal adenocarcinoma in clinical practice. Here, we investigated the epidemiologic patterns and causes of EsC. Using population based cancer data from the Surveillance, Epidemiology and End Results Program of the United States; we generated the most up-to-date stage distribution and 5-year relative survival by stage at diagnosis for 1998-2009. Special note should be given to the fact that esophageal cancer, mainly adenocarcinoma, is one of the very few cancers that is contributing to increasing death rates (20%) among males in the United States. To further explore the mechanism of development of EsC will hopefully decrease the incidence of EsC and improve outcomes.

[1]  M. Krasna,et al.  Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. , 2002, The Annals of thoracic surgery.

[2]  C. Percy,et al.  Cancer incidence and mortality in the United States, 1973-77. , 1981, National Cancer Institute monograph.

[3]  C. Reed,et al.  Surgical management of esophageal carcinoma. , 1999, The oncologist.

[4]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[5]  M. Hongo,et al.  Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity , 2009, Journal of gastroenterology and hepatology.

[6]  R. Sinha,et al.  Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[7]  E. Lengyel,et al.  Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.

[8]  M. Ebert,et al.  Current treatment approach to locally advanced esophageal cancer: is resection mandatory? , 2006, Future oncology.

[9]  J. Lagergren,et al.  Risk Factors for Esophageal Adenocarcinoma After Antireflux Surgery , 2013, Annals of surgery.

[10]  G. Ku,et al.  Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus. , 2012, Gastrointestinal cancer research : GCR.

[11]  M. Siddiqi,et al.  Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley—A high risk area , 2011, Molecular carcinogenesis.

[12]  K. Sugimachi,et al.  p53 polymorphism in human papillomavirus-associated esophageal cancer. , 2000, Cancer research.

[13]  P. Taylor,et al.  Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus.A prospective follow‐up study from Linxian, China , 1994, Cancer.

[14]  S. Fook-Chong,et al.  GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. , 2005, European journal of cancer.

[15]  Jeffrey W. Clark,et al.  The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer , 2006, American journal of clinical oncology.

[16]  F. Khuri,et al.  Risk Factors for Rising Incidence of Esophageal and Gastric Cardia Adenocarcinoma , 2013, Journal of Gastrointestinal Cancer.

[17]  C. Kim,et al.  [Clinicopathologic characteristics of adenocarcinoma in cardia according to Siewert classification]. , 2008, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[18]  L. Liang,et al.  Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions , 2012, Nature Genetics.

[19]  Hongbing Shen,et al.  Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations , 2011, Nature Genetics.

[20]  J. Fraumeni,et al.  Continuing climb in rates of esophageal adenocarcinoma: an update. , 1993, JAMA.

[21]  R. Munden,et al.  The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. , 2007, Seminars in Radiation Oncology.

[22]  V. Conteduca,et al.  Barrett's esophagus and esophageal cancer: an overview. , 2012, International journal of oncology.

[23]  G. Cooper,et al.  Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry. , 2008, Cancer detection and prevention.

[24]  Bo Zhu,et al.  Cyclin D1 G870A Polymorphism is a Risk Factor for Esophageal Cancer Among Asians , 2012, Cancer investigation.

[25]  J. Banai,et al.  [Siewert-Stein classification of adenocarcinoma of the esophagogastric junction]. , 2001, Magyar sebeszet.

[26]  R. Lambert,et al.  Endoscopy in screening for digestive cancer. , 2012, World Journal of Gastrointestinal Endoscopy.

[27]  J. Li Epidemiology of esophageal cancer in China. , 1982, National Cancer Institute monograph.

[28]  J. Chen,et al.  Hot beverage and food intake and esophageal cancer in southern China. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[29]  Min Hu Chen,et al.  Barrett's esophagus‐related diseases remain uncommon in China , 2011, Journal of digestive diseases.

[30]  J. Roth,et al.  p53 gene mutations in Barrett's epithelium and esophageal cancer. , 1991, Cancer research.

[31]  A. Sameer,et al.  Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study. , 2013, Molecular medicine reports.

[32]  M. Hollstein,et al.  Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. , 1996, Cancer research.

[33]  Z. Ling,et al.  Epidemiologic risk factors for esophageal cancer development. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[34]  T. Yoshikawa,et al.  Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma , 2013, Annals of Surgical Oncology.

[35]  S. Meltzer,et al.  Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. , 2005, Journal of the National Medical Association.

[36]  R. Sinha,et al.  Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference , 1997, International journal of cancer.

[37]  W. Hsu,et al.  Esophagogastric Junction Adenocarcinoma According to Siewert Classification in Taiwan , 2009, Annals of Surgical Oncology.

[38]  M. Blaser,et al.  Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[39]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[40]  N. Geller,et al.  Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy , 1985, Cancer.

[41]  G. Boeckxstaens,et al.  Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility. , 2009, Endoscopy.

[42]  K. Matsuo,et al.  Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. , 2011, Japanese journal of clinical oncology.

[43]  S. Zargar,et al.  High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. , 1992, Gut.

[44]  Sabha Rasool,et al.  Esophageal Cancer: Associated Factors with Special Reference to the Kashmir Valley , 2012, Tumori.

[45]  W. Blot Invited commentary: more evidence of increased risks of cancer among alcohol drinkers. , 1999, American journal of epidemiology.

[46]  H. Daiko,et al.  Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in Japan , 2012, Annals of Surgical Oncology.

[47]  J. Lagergren,et al.  Recent developments in esophageal adenocarcinoma , 2013, CA: a cancer journal for clinicians.

[48]  D. Cescon,et al.  p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. , 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[49]  J. Fraumeni,et al.  Time-related factors in cancer epidemiology. , 1987, Journal of chronic diseases.

[50]  U. Ghoshal,et al.  Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. , 2007, Cancer detection and prevention.

[51]  Ping Yang,et al.  Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects. , 2012, Cancer epidemiology.

[52]  N. Chainani-Wu Diet and Oral, Pharyngeal, and Esophageal Cancer , 2002, Nutrition and cancer.

[53]  Y. Guanrei,et al.  Endoscopic Surveys in High-risk and Low-risk Populations for Esophageal Cancer in China with Special Reference to Precursors of Esophageal Cancer , 1987, Endoscopy.

[54]  S. Evans,et al.  Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma , 2005, Cancer.

[55]  G. Kuang,et al.  Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population , 2003, International journal of cancer.

[56]  P. Fockens,et al.  Eradication of Barrett Esophagus with Early Neoplasia by Radiofrequency Ablation, with or without Endoscopic Resection , 2008, Journal of Gastrointestinal Surgery.

[57]  N. Shaheen,et al.  A cost-utility analysis of ablative therapy for Barrett's esophagus. , 2009, Gastroenterology.

[58]  R. Sinha,et al.  A Prospective Study of Red and Processed Meat Intake in Relation to Cancer Risk , 2007, PLoS medicine.

[59]  K. Matsuo,et al.  Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. , 2011, Japanese journal of clinical oncology.

[60]  R. V. van Schaik,et al.  Sequencing: not always the "gold standard". , 2004, Clinical chemistry.

[61]  S. Shi,et al.  Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  J. Bosset,et al.  Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. , 2012, European journal of cancer.

[63]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[64]  W. Kim,et al.  Should Adenocarcinoma of the Esophagogastric Junction Be Classified as Esophageal Cancer? A Comparative Analysis According to the Seventh AJCC TNM Classification , 2012, Annals of surgery.

[65]  N. Probst-Hensch,et al.  The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. , 2005, Carcinogenesis.

[66]  W. Curvers,et al.  Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. , 2008, Gastrointestinal endoscopy.

[67]  P. Neuhaus,et al.  Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[68]  R. Pugliese,et al.  Evaluation of Siewert classification in gastro‐esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? , 2005, Journal of surgical oncology.

[69]  D. Ransohoff,et al.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. , 2002, JAMA.

[70]  R. Sinha,et al.  Meat Consumption and Risk of Esophageal and Gastric Cancer in a Large Prospective Study , 2011, The American Journal of Gastroenterology.

[71]  W. Blot,et al.  The changing epidemiology of esophageal cancer. , 1999, Seminars in oncology.

[72]  Patricia L. Blount,et al.  Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.